A Newton-based venture capital firm that invests in health care and life sciences companies
Mediphase Venture Partners is a venture capital firm in Newton that prefers to invest in life sciences and healthcare companies with a focus on biopharmaceutical technology and life sciences information. Founded in 1999 by Lawrence Miller and Paul Howard in Newton, Massachusetts, the firm invests in early stage ventures, late stage ventures, and private equity rounds. The notable investment portfolio of Mediphase Venture Partners includes Relypsa,Tetraphase Pharmaceuticals, Wellpartner, and Concert PharmaceuticalsConcert Pharmaceuticals. As of February 2020, Mediphase Venture Partners has made 21 investments. Their most recent investment was on Aug 14, 2012, when Relypsa raised $80M. Mediphase Venture Partners has had seven exits, the most notable of which include Relypsa, Concert Pharmaceuticals, and PatientKeeper.